BACKGROUND: Perinatal factors including high birth weight have been found to be associated with acute lymphoblastic leukemia (ALL) in case-control studies. However, to the best of our knowledge, these findings have seldom been examined in large population-based cohort studies, and the specific contributions of gestational age and fetal growth remain unknown. METHODS: The authors conducted a national cohort study of 3,569,333 individuals without Down syndrome who were born in Sweden between 1973 and 2008 and followed for the incidence of ALL through 2010 (maximum age, 38 years) to examine perinatal and familial risk factors. RESULTS: There were 1960 ALL cases with 69.7 million person-years of follow-up. After adjusting for potential confounders, risk factors for ALL included high fetal growth (incidence rate ratio [IRR] per additional 1 standard deviation, 1.07; 95% confidence interval [95% CI], 1.02-1.11 [P =.002]; and IRR for large vs appropriate for gestational age, 1.22; 95% CI, 1.06-1.40 [P =.005]), first-degree family history of ALL (IRR, 7.41; 95% CI, 4.60-11.95 [P<.001]), male sex (IRR, 1.20; 95% CI, 1.10-1.31 [P<.001]), and parental country of birth (IRR for both parents born in Sweden vs other countries, 1.13; 95% CI, 1.00-1.27 [P =.045]). These risk factors did not appear to vary by patient age at the time of diagnosis of ALL. Gestational age at birth, season of birth, birth order, multiple birth, parental age, and parental education level were not found to be associated with ALL. CONCLUSIONS: In this large cohort study, high fetal growth was found to be associated with an increased risk of ALL in childhood through young adulthood, independent of gestational age at birth, suggesting that growth factor pathways may play an important long-term role in the etiology of ALL.
BACKGROUND: Perinatal factors including high birth weight have been found to be associated with acute lymphoblastic leukemia (ALL) in case-control studies. However, to the best of our knowledge, these findings have seldom been examined in large population-based cohort studies, and the specific contributions of gestational age and fetal growth remain unknown. METHODS: The authors conducted a national cohort study of 3,569,333 individuals without Down syndrome who were born in Sweden between 1973 and 2008 and followed for the incidence of ALL through 2010 (maximum age, 38 years) to examine perinatal and familial risk factors. RESULTS: There were 1960 ALL cases with 69.7 million person-years of follow-up. After adjusting for potential confounders, risk factors for ALL included high fetal growth (incidence rate ratio [IRR] per additional 1 standard deviation, 1.07; 95% confidence interval [95% CI], 1.02-1.11 [P =.002]; and IRR for large vs appropriate for gestational age, 1.22; 95% CI, 1.06-1.40 [P =.005]), first-degree family history of ALL (IRR, 7.41; 95% CI, 4.60-11.95 [P<.001]), male sex (IRR, 1.20; 95% CI, 1.10-1.31 [P<.001]), and parental country of birth (IRR for both parents born in Sweden vs other countries, 1.13; 95% CI, 1.00-1.27 [P =.045]). These risk factors did not appear to vary by patient age at the time of diagnosis of ALL. Gestational age at birth, season of birth, birth order, multiple birth, parental age, and parental education level were not found to be associated with ALL. CONCLUSIONS: In this large cohort study, high fetal growth was found to be associated with an increased risk of ALL in childhood through young adulthood, independent of gestational age at birth, suggesting that growth factor pathways may play an important long-term role in the etiology of ALL.
Authors: Lisa Lyngsie Hjalgrim; Tine Westergaard; Klaus Rostgaard; Kjeld Schmiegelow; Mads Melbye; Henrik Hjalgrim; Eric A Engels Journal: Am J Epidemiol Date: 2003-10-15 Impact factor: 4.897
Authors: Judith E Lupatsch; Christian Kreis; Garyfallos Konstantinoudis; Marc Ansari; Claudia E Kuehni; Ben D Spycher Journal: Cancer Causes Control Date: 2021-04-20 Impact factor: 2.506
Authors: Elva Jiménez-Hernández; Arturo Fajardo-Gutiérrez; Juan Carlos Núñez-Enriquez; Jorge Alfonso Martín-Trejo; Laura Eugenia Espinoza-Hernández; Janet Flores-Lujano; José Arellano-Galindo; Aurora Medina-Sanson; Rogelio Paredes-Aguilera; Laura Elizabeth Merino-Pasaye; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Rosa Martha Espinosa-Elizondo; Raquel Amador-Sánchez; Juan José Dosta-Herrera; Javier Anastacio Mondragón-García; Heriberto Valdés-Guzmán; Laura Mejía-Pérez; Gilberto Espinoza-Anrubio; María Minerva Paz-Bribiesca; Perla Salcedo-Lozada; Rodolfo Ángel Landa-García; Rosario Ramírez-Colorado; Luis Hernández-Mora; María Luisa Pérez-Saldivar; Marlene Santamaría-Ascencio; Anselmo López-Loyola; Arturo Hermilo Godoy-Esquivel; Luis Ramiro García-López; Alison Ireri Anguiano-Ávalos; Karina Mora-Rico; Alejandro Castañeda-Echevarría; Roberto Rodríguez-Jiménez; José Alberto Cibrian-Cruz; Karina Anastacia Solís-Labastida; Rocío Cárdenas-Cardos; Armando Martínez-Avalos; Luz Victoria Flores-Villegas; José Gabriel Peñaloza-González; Ana Itamar González-Ávila; Martha Beatriz Altamirano-García; Norma López-Santiago; Martin Sánchez-Ruiz; Roberto Rivera-Luna; Luis Rodolfo Rodríguez-Villalobos; Francisco Hernández-Pérez; Jaime Ángel Olvera-Durán; Luis Rey García-Cortés; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; Cesar Raúl González-Bonilla; Vilma Carolina Bekker-Méndez; Silvia Jiménez-Morales; Haydee Rosas-Vargas; Juan Manuel Mejía-Aranguré Journal: Cancer Med Date: 2018-03-13 Impact factor: 4.452
Authors: Åsa Magnusson; Hannele Laivuori; Anne Loft; Nan B Oldereid; Anja Pinborg; Max Petzold; Liv Bente Romundstad; Viveca Söderström-Anttila; Christina Bergh Journal: Front Pediatr Date: 2021-06-23 Impact factor: 3.418